 NEW YORK, Oct. 28, 2020 PRNewswire -- AIkido Pharma Inc. Nasdaq: AIKI AIkido or the Company today provided an update on its preclinical work on its next-generation chemotherapeutic, DHA-dFdC, and the solid lipid nanoparticle SLN drug delivery system to treat pancreatic cancer,... 